tiprankstipranks
Pharming Group (DE:PHGN)
FRANKFURT:PHGN

Pharming Group (PHGN) Financial Statements

2 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Pharming Group is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is €<0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 54.24M$ 50.15M$ 46.62M$ 53.71M
Gross Profit-$ 51.85M$ 46.12M$ 41.74M$ 47.98M
EBIT-$ 10.53M$ 20.91M$ 5.61M$ 4.22M
EBITDA-$ 12.48M$ 22.98M$ 7.80M$ 15.81M
Net Income Common Stockholders-$ 9.10M$ 15.74M$ 3.46M$ 2.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.90M$ 188.70M$ 189.96M$ 189.67M$ 169.51M
Total Assets$ 425.80M$ 382.32M$ 393.90M$ 392.80M$ 350.92M
Total Debt$ 166.69M$ 139.18M$ 149.00M$ 157.79M$ 142.87M
Net Debt$ 163.79M$ -49.52M$ -40.96M$ -31.89M$ -26.64M
Total Liabilities$ 242.90M$ 182.07M$ 194.23M$ 198.78M$ 180.53M
Stockholders Equity$ 205.87M$ 200.25M$ 199.67M$ 194.02M$ 170.39M
Cash Flow-
Free Cash Flow-$ 12.51M$ 2.81M$ 234.00K$ 9.21M
Operating Cash Flow-$ 12.62M$ 4.00M$ 609.00K$ 15.14M
Investing Cash Flow-$ -298.00K$ 6.39M$ -374.00K$ -6.15M
Financing Cash Flow-$ -1.92M$ -451.00K$ -2.89M$ -1.54M
Currency in USD

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis